FDCDDQ
DFTX icon

Federation des caisses Desjardins du Quebec’s Definium Therapeutics DFTX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$428K Sell
9,104
-3,540
-28% -$87.5K ﹤0.01% 1415
2026
Q1 		$239K Buy
12,644
+2,040
+19% +$34.6K ﹤0.01% 1476
2025
Q4 		$142K Sell
10,604
-11,388
-52% -$141K ﹤0.01% 1585
2025
Q3 		$259K Buy
21,992
+570
+3% +$5.32K ﹤0.01% 1422
2025
Q2 		$139K Sell
21,422
-1,000
-4% -$6.58K ﹤0.01% 1301
2025
Q1 		$131K Buy
22,422
+1,000
+5% +$7.16K ﹤0.01% 1261
2024
Q4 		$149K Buy
21,422
+1,500
+8% +$10.3K ﹤0.01% 1192
2024
Q3 		$113K Buy
19,922
+2,706
+16% +$18.8K ﹤0.01% 1227
2024
Q2 		$124K Buy
17,216
+3,095
+22% +$27.1K ﹤0.01% 1203
2024
Q1 		$149K Sell
14,121
-66
-0.5% -$376 ﹤0.01% 1137
2023
Q4 		$51.8K Hold
14,187
– – ﹤0.01% 1296
2023
Q3 		$44.4K Hold
14,187
– – ﹤0.01% 1343
2023
Q2 		$50.4K Hold
14,187
– – ﹤0.01% 1326
2023
Q1 		$44.7K Buy
14,187
+13,200
+1,337% +$43.9K ﹤0.01% 1354
2022
Q4 		$2.17K Hold
987
– – ﹤0.01% 2196
2022
Q3 		$3.45K Sell
987
-1
-0.1% -$10 ﹤0.01% 2155
2022
Q2 		$9.48K Sell
988
-116
-11% -$1.47K ﹤0.01% 1969
2022
Q1 		$18.3K Hold
1,104
– – ﹤0.01% 1849
2021
Q4 		$22.8K Sell
1,104
-7
-0.6% -$223 ﹤0.01% 1795
2021
Q3 		$38.7K Sell
1,111
-40
-3% -$1.73K ﹤0.01% 1676
2021
Q2 		$59.6K Buy
+1,151
New +$60.4K ﹤0.01% 1551

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's DFTX Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec reduced its Definium Therapeutics (DFTX) stake by 28% in Q2 2026, selling an estimated $87.5K and leaving 9,104 shares worth $428K. The position accounts for ﹤0.01% of the portfolio, ranked #1415.

Federation des caisses Desjardins du Quebec first reported a position in DFTX in Q2 2021 and has held it in 21 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 9,104 shares of Definium Therapeutics worth $428K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec sold 3,540 Definium Therapeutics shares in Q2 2026, an estimated $87.5K.
  • Definium Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1415 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Definium Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.